|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim DY and Park HL: Breast cancer risk
prediction in Korean women: Review and perspectives on personalized
breast cancer screening. J Breast Cancer. 23:331–342. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jin X and Mu P: Targeting breast cancer
metastasis. Breast Cancer (Auckl). 9 (Suppl 1):S23–S34. 2015.
|
|
4
|
Sternlicht MD and Werb Z: How matrix
metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol.
17:463–516. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu H, Zang C, Fenner MH, Possinger K and
Elstner E: PPARgamma ligands and ATRA inhibit the invasion of human
breast cancer cells in vitro. Breast Cancer Res Treat. 79:63–74.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hong OY, Youn HJ, Jang HY, Jung SH, Noh
EM, Chae HS, Jeong YJ, Kim W, Kim CH and Kim JS: Troglitazone
inhibits matrix metalloproteinase-9 expression and invasion of
breast cancer cell through a peroxisome proliferator-activated
receptor γ-dependent mechanism. J Breast Cancer. 21:28–36. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang YY, Zhe H and Zhao R: Preclinical
evidences toward the use of triterpenoid CDDO-Me for solid cancer
prevention and treatment. Mol Cancer. 13:302014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lapillonne H, Konopleva M, Tsao T, Gold D,
McQueen T, Sutherland RL, Madden T and Andreeff M: Activation of
peroxisome proliferator-activated receptor gamma by a novel
synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic
acid induces growth arrest and apoptosis in breast cancer cells.
Cancer Res. 63:5926–5939. 2003.PubMed/NCBI
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jang HY, Hong OY, Youn HJ, Kim MG, Kim CH,
Jung SH and Kim JS: 15d-PGJ2 inhibits NF-κB and AP-1-mediated MMP-9
expression and invasion of breast cancer cell by means of a heme
oxygenase-1-dependent mechanism. BMB Rep. 53:212–217. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bauvois B: New facets of matrix
metalloproteinases MMP-2 and MMP-9 as cell surface transducers:
Outside-in signaling and relationship to tumor progression. Biochim
Biophys Acta. 1825:29–36. 2012.PubMed/NCBI
|
|
12
|
Stetler-Stevenson WG: Matrix
metalloproteinases in angiogenesis: A moving target for therapeutic
intervention. J Clin Invest. 103:1237–1241. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hong OY, Jang HY, Park KH, Jeong YJ, Kim
JS and Chae HS: Triptolide inhibits matrix metalloproteinase-9
expression and invasion of breast cancer cells through the
inhibition of NF-κB and AP-1 signaling pathways. Oncol Lett.
22:5622021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shin Y, Yoon SH, Choe EY, Cho SH, Woo CH,
Rho JY and Kim JH: PMA-induced up-regulation of MMP-9 is regulated
by a PKCalpha-NF-kappaB cascade in human lung epithelial cells. Exp
Mol Med. 39:97–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim JM, Noh EM, Kim HR, Kim MS, Song HK,
Lee M, Yang SH, Lee GS, Moon HC, Kwon KB and Lee YR: Suppression of
TPA-induced cancer cell invasion by Peucedanum japonicum Thunb.
extract through the inhibition of PKCα/NF-κB-dependent MMP-9
expression in MCF-7 cells. Int J Mol Med. 37:108–114. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee YR, Noh EM, Han JH, Kim JM, Hwang BM,
Kim BS, Lee SH, Jung SH, Youn HJ, Chung EY and Kim JS: Sulforaphane
controls TPA-induced MMP-9 expression through the NF-κB signaling
pathway, but not AP-1, in MCF-7 breast cancer cells. BMB Rep.
46:201–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Uzzo RG, Crispen PL, Golovine K, Makhov P,
Horwitz EM and Kolenko VM: Diverse effects of zinc on NF-kappaB and
AP-1 transcription factors: Implications for prostate cancer
progression. Carcinogenesis. 27:1980–1990. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Helbig G, Christopherson KW II,
Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE and
Nakshatri H: NF-kappaB promotes breast cancer cell migration and
metastasis by inducing the expression of the chemokine receptor
CXCR4. J Biol Chem. 278:21631–21638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lichtor T, Spagnolo A, Glick RP and
Feinstein DL: PPAR-gamma thiazolidinedione agonists and
immunotherapy in the treatment of brain tumors. PPAR Res.
2008:5474702008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arif IS, Hooper CL, Greco F, Williams AC
and Boateng SY: Increasing doxorubicin activity against breast
cancer cells using PPARγ-ligands and by exploiting circadian
rhythms. Br J Pharmacol. 169:1178–1188. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Krieger-Hinck N, Schumacher U, Müller A
and Valentiner U: The effect of the PPAR-gamma agonist
rosiglitazone on neuroblastoma SK-N-SH cells in a metastatic
xenograft mouse model. Oncol Res. 8:387–393. 2010.PubMed/NCBI
|
|
23
|
Wang YY, Yang YX, Zhe H, He ZX and Zhou
SF: Bardoxolone methyl (CDDO-Me) as a therapeutic agent: An update
on its pharmacokinetic and pharmacodynamic properties. Drug Des
Devel Ther. 8:2075–2088. 2014.PubMed/NCBI
|
|
24
|
Marx N, Sukhova G, Murphy C, Libby P and
Plutzky J: Macrophages in human atheroma contain PPARgamma:
Differentiation-dependent peroxisomal proliferator-activated
receptor gamma(PPARgamma) expression and reduction of MMP-9
activity through PPARgamma activation in mononuclear phagocytes in
vitro. Am J Pathol. 153:17–23. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shishodia S, Sethi G, Konopleva M,
Andreeff M and Aggarwal BB: A synthetic triterpenoid, CDDO-Me,
inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF
and chemotherapeutic agents through down-regulation of expression
of nuclear factor kappaB-regulated gene products in human leukemic
cells. Clin Cancer Res. 12:1828–1838. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luo X, Wu J and Wu G: PPARγ activation
suppresses the expression of MMP9 by downregulating NF-κB post
intracerebral hemorrhage. Neurosci Lett. 752:1357702021. View Article : Google Scholar : PubMed/NCBI
|
